Artificial Intelligence | Machine Learning InterVenn Biosciences | Unique, Powerful Liquid Biopsy Platform

Enterprise, Biotech, Healthcare, Biomarkers, Cancer Detection, Cancer Treatment, Drug Discovery, Glycoproteomics South San Francisco , California , United States

Artificial Intelligence | Machine Learning

InterVenn Biosciences | Unique, Powerful Liquid Biopsy Platform

Biotech, Healthcare, Biomarkers, Cancer Detection, Cancer Treatment, Drug Discovery, Glycoproteomics

South San Francisco , California , United States

InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with applications from the Vista suite of solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression.

B2B

101 to 250

N/A

Scaling Up

2017

Healthcare
Biotechnology

N/A

Production
Service

Yes

Active

Machine Learning

Early Cancer Detection Tool

N/A

Software

GitHub

Linux

AWS Cloud

Google Cloud

Tensorflow

Pytorch

Python

Machine Learning Algorithm

Jun 2021

InterVenn Biosciences Announces Clinical Validation of World’s First Glycoproteomic Diagnostic Test

Apr 2021

InterVenn Biosciences Announces that Nobel Laureate James P. Allison, PhD, has Joined the Company’s Board of Advisors

$201M

Company was founded 2017 and it took almost 4 years (Aug 2021) to raise first external round

Date

Round

$ Raised

Investors

08/02/2021

Series C

$201M

True Ventures, Irving Investors, Heritage Provider Network, Jenny Rooke, Anzu Partners, Amplify Partners

Date : 08/02/2021

Round: Series C

$ Raised: $201M

Investors: True Ventures, Irving Investors, Heritage Provider Network, Jenny Rooke, Anzu Partners, Amplify Partners

Investors

Interested in researching InterVenn Biosciences?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about InterVenn Biosciences

Request a Demo - Deal Souring Platform

Aldo Carrascoso
CEO and Co-Founder

Randolph Barr
Chief Information & Security Officer

Melanie Barr
Human Resources Manager

Rj Covington
Senior Talent Acquisition Partner

Gavin Haney
Senior Director of Marketing

Maryam Hosseini
Vice President of Operations

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ InterVenn Biosciences

InterVenn Biosciences - Manage Profile